Stockwinners Market Radar for July 13, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:23 EDT Intuitive Machines' lunar lander passes spacecraft test run - The company states: "Intuitive Machines has successfully conducted a complete spacecraft test run of its Nova-C lunar lander - a significant technical achievement in the Company's efforts to completing its lunar lander. The complete spacecraft test run verified Nova-C's flight software, flight avionics, liquid oxygen and liquid Methane loading, high-pressure helium system performance, propulsion system complete functionality, and culminating in a hot fire of the Nova-C main engine." Steve Altemus, CEO, stated. "This test run represents a crucial step forward in validating the performance of the entire Nova-C lunar lander system on its way to the Moon. The technical excellence the Intuitive Machines team showed during this comprehensive test has propelled the Company closer to delivering Nova-C to Florida for launch."

20:11 EDT Cathie Wood's ARK Investment bought 1.43M shares of Quantum-Si today

19:02 EDT Canfor Pulp's Northwood Pulp Mill to resume operations - Following the announcement of a tentative agreement in the labour dispute at B.C. ports, Canfor Pulp Products Inc. is announcing that Northwood Pulp Mill in Prince George will resume production next week (the week of July 17).

18:17 EDT Biocept announces passing of Board Chair M. Faye Wilson - Biocept announces that M. Faye Wilson, Board Chair, passed away unexpectedly on Monday, July 10. The Biocept Board of Directors has appointed Bruce E. Gerhardt as Board Chair and Dr. Marsha A. Chandler as Board Vice Chair.

17:46 EDT Visa officer Taneja sells $5.5M in company shares - Visa officer Rajat Taneja disclosed the sale of 22,700 shares of company stock at $240.21 per share on July 11, for a total transaction amount of $5,452,742.

17:28 EDT Terra Property Trust reaffirms plans to merge with Western Asset Mortgage - Terra Property Trust reaffirmed its commitment to the previously announced combination with Western Asset Mortgage Capital (WMC) to form a REIT that is expected to have approximately $1.2B in assets and $436M of adjusted book value upon completion of the merger. On July 13, AG Mortgage Investment Trust (MITT) announced that it submitted an unsolicited non-binding proposal to the Board of Directors of WMC to acquire WMC. TPT believes that its proposed combination with WMC represents the most compelling transaction for stockholders of WMC. TPT continues to believe that the TPT Merger is a compelling combination and a unique opportunity to establish a diversified REIT that prioritizes capital preservation, maintains a robust balance sheet, and consistently generates attractive risk-adjusted returns for its shareholders. TPT also believes that the TPT Merger could be consummated more quickly and provides more certainty of execution compared to the MITT Proposal. TPT's Merger Agreement has already been negotiated and executed and, for the reasons noted above, the voting agreement nearly guarantees a successful TPT stockholder vote.

17:17 EDT Methode Electronics initiates discontinuation of Dabir Surface - Methode Electronics initiated the discontinuation of the Dabir Surfaces business. The company is executing a wind down process of the Dabir business. The impact from severance, asset impairments, and other associated costs to FY24 pre-tax income is expected to be $1.5M-$3.5M with most of the cost to be recognized in the first half of FY24. The wind down process is expected to be completed by approximately the end of FY24 in accordance with contractual and regulatory commitments. The company expects to provide additional details on the Dabir discontinuation when it reports its FY24 Q1 results.

17:02 EDT AptarGroup increases quarterly dividend by 7.9% to 41c per share - AptarGroup declared a quarterly cash dividend of 41c per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share. The payment date is August 17 to stockholders of record as of July 27.

16:50 EDT Roblox chief product officer Bronstein sells 14,521 class A shares - In a regulatory filing, Roblox chief product officer Manuel Bronstein disclosed the sale of 14,521 class A common shares of the company on July 11 at a price of $45 per share.

16:39 EDT Aziyo voluntarily recalls bone repair products after MTB infections in patient - Aziyo Biologics announced a voluntary recall of its viable bone matrix products, which are bone repair products made from human tissue that are used primarily in orthopedic and spinal procedures. Notice of the voluntary recall was issued to centers after the Company learned of post-surgical Mycobacterium tuberculosis or MTB, infections in two patients treated with viable bone matrix product from a single donor lot. Prior to release, samples from this specific lot had tested negative for MTB by an independent laboratory using a nucleic acid test that is designed to specifically detect the MTB organism. Aziyo is fully cooperating and investigating the events in coordination with the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention. Out of an abundance of caution, the Company has suspended shipments of all viable bone matrix products from all donor lots. The Company is also working closely with CDC staff to notify physicians of the patients who received the particular donor lot at issue to initiate post-exposure prophylaxis. "We are taking immediate action to safeguard patients by implementing a full product recall as we work with the CDC to investigate this event," said Dr. Randy Mills, President and Chief Executive Officer of Aziyo Biologics. "The people of Aziyo care deeply about the patients we serve and will continue to work with the medical community, patients, and regulatory authorities as we gather additional information."

16:35 EDT Theseus Pharmaceuticals Inc trading resumes

16:31 EDT Funko CEO Brian Mariotti to take leave of absence, cease serving as CEO - Funko announced that Brian Mariotti will take a leave of absence and cease serving as Funko's CEO with full support from the company's Board of Directors. Effective immediately, the Board of Directors appointed director Michael Lunsford as interim CEO and will also commence a thorough search for a new CEO including internal and external candidates. Mariotti remains a member of the Funko Board of Directors. "Funko has been my labor of love for nearly two decades," said Mariotti. "While I'm going to step away from the day-to-day business to recharge my batteries, I plan to stay active on our Board. I hope to come back and contribute to Funko again in new creative ways. I look forward to seeing our team and fans at San Diego Comic-Con next week." Lunsford, who joined the Funko Board of Directors in 2018, previously served as Chair of the Compensation Committee and as a member of the Audit Committee.

16:26 EDT Ameresco completes solar installation with Valmont Industies - Ameresco (AMRC) announced the completion of a solar installation with Valmont Industries (VMI). The solar installation on-site at the Bristol, IN facility is a model for Valmont Industries, one of the largest producers of utility structures in North America and is designed to offset 100% of the plant's electricity usage. As part of the agreement, Ameresco installed 718 kilowatts-direct current/500 kilowatts-alternating current of ground-mounted PV modules utilizing Valmont's very-own racking and Convert single-axis tracking system. The completed system will produce approximately 980,000 kWh of electricity annually, offsetting nearly 766 tons of carbon dioxide emissions in its first year alone. Over its 25-year expected useful life, the installation will offset approximately 18,040 tons of emissions.

16:23 EDT Theseus Pharmaceuticals to resume trading at 4:35 pm ET - Theseus Pharmaceuticals shares are scheduled to resume trading at 4:35 pm ET, with quotation set to resume at 4:30 pm ET, according to Nasdaq. Theseus Pharmaceuticals trading was halted, news pending, ahead of the company announcing that it is discontinuing enrollment in the ongoing phase 1/2 study and terminating development of THE-630 in patients with gastrointestinal stromal tumors, or GIST.

16:21 EDT Samsara CEO Biswas sells 89,800 class A shares - In a regulatory filing, Samsara CEO Sanjit Biswas disclosed the sale of 89,800 class A common shares of the company on July 11 at a price of $27.698 per share.

16:20 EDT NYSE to commence delisting proceedings against Azure Power - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the equity shares of Azure Power Global Limited - ticker symbol AZRE - from the NYSE. Trading in the company's equity shares will be suspended immediately. "NYSE Regulation reached its decision that the company's equity shares are not suitable for listing, because the company is a late filer and has not filed with the Securities and Exchange Commission its annual report on Form 20-F for the fiscal year ended March 31, 2022 and current report on Form 6-K for the half year ended September 30, 2022. The company informed the NYSE and made public disclosure on July 13, 2023 that it will not be able to complete its Delayed Filings by August 16, 2023, which is the maximum time allowed under Section 802.01E of the NYSE's Listed Company Manual. The company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Equity Shares upon completion of all applicable procedures, including any appeal by the company of the NYSE Regulation staff's decision." Reference Link

16:17 EDT Commercial Metals acquires EDSCO Fasteners, terms not disclosed - Commercial Metals Company announced the purchase of EDSCO Fasteners, a provider of anchoring solutions for the electrical transmission market, from MiddleGround Capital. EDSCO's custom engineered line of anchor cages, bolts, and fasteners are manufactured principally from rebar and used primarily to secure high voltage electrical transmission poles to concrete foundations. EDSCO serves the North American market from four manufacturing plants located in Texas, Utah, Tennessee, and North Carolina. Since its founding in 1985, the company has grown to become the nation's largest provider of anchor cages for concrete reinforcement and has developed a strong reputation for customer service and reliability.

16:15 EDT Leslie's CFO Steve Weddell to step down, Scott Bowman to succeed - Leslie's also announced that Scott Bowman has been appointed CFO effective August 7. Bowman will join the company on July 17 and serve as CFO designate through August 6. Steve Weddell, who is stepping down as CFO effective August 7, will remain an advisor to the company through December 31 to facilitate the transition.

16:10 EDT Neurocrine Chief Medical Officer to retire - The company states: "On July 10, 2023, Eiry W. Roberts, M.D., notified Neurocrine Biosciences, Inc. (the "Company") of her decision to retire in 2025 from her position as Chief Medical Officer of the Company. Dr. Roberts has not determined her last day of employment with the Company in 2025 and will remain in her position until her replacement has been on-boarded with the Company. The Company has initiated a search for a replacement Chief Medical Officer. Dr. Roberts plans to retire for personal reasons, not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices."

16:07 EDT Vistagen receives notice of allowance for AV-101 Canadian patent - Vistagen announced that the Canadian Intellectual Property Office (CIPO) issued a Notice of Allowance for a patent related to the use of AV-101 for reduction of dyskinesia (sudden uncontrolled movements) induced by the administration of levodopa (L-Dopa), the most commonly prescribed medication for treatment of Parkinson's disease (PD). AV-101 is the Company's oral prodrug antagonist at the NMDAR (N-methyl-D-aspartate receptor) glycine site. The patent, once granted, will not expire until at least 2034. The U.S. Patent and Trademark Office (USPTO) granted a related U.S. patent for Vistagen's AV-101 and similar patents have been granted or are pending in several additional major pharmaceutical markets. Preclinical data previously published in the international, peer-reviewed journal, Cells, demonstrate the effects of AV-101 in a widely-used MPTP non-human primate model for reproducing motor complications of PD, including dyskinesia observed in many PD patients treated with L-Dopa. In this study, AV-101's efficacy against L-Dopa induced dyskinesia (LID) was measured through behavioral scores on a dyskinesia scale, and a Parkinsonian disability scale was used to measure L-Dopa antiparkinsonian efficacy. The study demonstrated that AV-101 significantly (p = 0.01) reduced LID without affecting the timing, extent, or duration of the therapeutic benefits of L-Dopa. No adverse events attributable to the drug were observed during the study. The preclinical study was conducted by Dr. Therese Di Paolo, Emeritus Professor in the Faculty of Pharmacy at Laval University in Canada and among the world's leading researchers focused on PD and LID, pursuant to Vistagen's research agreement with CHU de Quebec - Universite Laval Research Center in Quebec, Canada.

16:05 EDT Acadia acquires ex-North American rights to trofinetide - Acadia Pharmaceuticals announced that it has expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American rights to the drug as well as global rights in Rett syndrome and Fragile X syndrome to Neuren's development candidate NNZ-2591. In April of this year, Acadia launched trofinetide in the United States under the brand name DAYBUE as the first and only drug approved for the treatment of Rett syndrome. "This expanded worldwide agreement solidifies Acadia's position as the global leader in addressing the unmet needs of people with Rett syndrome," said Steve Davis, Acadia's President and Chief Executive Officer. "We have successfully delivered DAYBUE, the first FDA-approved therapy that treats the core symptoms of Rett syndrome, and are deeply committed to broadening access to this important therapy for patients worldwide." In addition to expanding access to trofinetide outside of North America, this agreement gives Acadia exclusive worldwide rights to NNZ-2591 in both Rett syndrome and Fragile X syndrome. NNZ-2591 is an investigational synthetic analogue of cyclo-glycyl-proline (cGP) which results from the breakdown of human insulin-like growth factor 1 (IGF-1). NNZ-2591 is currently under development by Neuren in four other rare neurodevelopmental syndromes.

15:24 EDT SAG-AFTRA announces decision to go on strike - SAG-AFTRA, which identifies itself as "the world's largest labor union representing performers and broadcasters," has announced that its members have elected to go on strike. Publicly traded studio owners and content producers include Netflix (NFLX), Amazon (AMZN), Apple (AAPL), Comcast (CMCSA), Disney (DIS), Lionsgate (LGF.A), Sony (SONY), Warner Bros. Discovery (WBD) and Paramount (PARA). Reference Link

15:21 EDT Emmaus gets marketing authorization for SCD treatment Endari in Oman - Emmaus Life Sciences announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari or L-glutamine oral powder in the country to treat sickle cell disease in patients five years of age and older.There are around 3,000 patients with sickle cell disorders in Oman1. The birth prevalence of infants with hemoglobin disorders was 3.5-4.7 per 1,000. Around 6% of Omanis are carriers of the gene for sickle cell anaemia ."We are delighted to receive marketing authorization for Endari in Oman, where sickle cell disease is a significant public health issue that affects thousands of patients and their families," said Dr. Yutaka Niihara, M.D., M.P.H., Chairman and Chief Executive Officer of Emmaus. "This approval marks another milestone in our mission to improve the lives of people with sickle cell disease around the world."

14:44 EDT Air Products hydrogen refueler to be stationed at airport for fuel cell vehicles - Air Products announced that it has been selected by Edmonton International Airport as the hydrogen and technology provider for Alberta's first hydrogen fuel cell passenger vehicle fleet. Under the agreement, Air Products will station a mobile hydrogen refueler at the airport to provide hydrogen for the fleet of Toyota Mirai hydrogen fuel cell vehicles. The airport will begin with a fleet of five hydrogen fuel cell vehicles to be used by employees and plans to expand the fleet to as many as 100 cars to serve as a taxi service at the airport. Fueling of the vehicles will begin next week. Myron Keehn, President and CEO of Edmonton Airports, including Edmonton International Airport, made the announcement today during a luncheon with Toyota Canada, where they unveiled plans to partner to create the Province's first hydrogen fuel cell passenger vehicle fleet. "Air Products is proud to support Edmonton International Airport in this first-mover project to establish the first passenger hydrogen fuel cell vehicle fleet in Alberta," said Eric Guter, Air Products' Global Vice President, Hydrogen for Mobility. "Access to clean hydrogen fueling infrastructure is key to the energy transition and efforts to decarbonize transportation. Air Products' innovative and efficient mobile fuelers will accelerate the use of hydrogen as an emissions-free transportation fuel as permanent hydrogen infrastructure is built in Western Canada."

13:59 EDT Ault Inc. trading halted, volatility trading pause

13:31 EDT FTC appeals decision on Microsoft-Activision deal to Ninth Circuit - Plaintiff Federal Trade Commission has appealed to the United States Court of Appeals for the Ninth Circuit of Judge Jacqueline Scott Corley's opinion dated July 10 and entered on the court's docket on July 11 at ECF Docket Number 305 denying the FTC's request for a preliminary injunction pursuant to Federal Trade Commission Act Section 13(b), 15 U.S.C. 53(b), a filing with the court shows. The recent U.S. federal court decision cleared the path for Microsoft (MSFT) to acquire Activision Blizzard (ATVI), which the FTC is opposing.

13:10 EDT Collins Aerospace selected for U.S. Air Force award for new training systems - Collins Aerospace, an RTX business, was awarded an indefinite delivery, indefinite quantity contract with the U.S. Air Force to support development of new training systems. "The contract for Training Systems Acquisition issued under the U.S. Air Force Life Cycle Management Center sets the stage for procuring a variety of training systems elements including development, production, integration and sustainment contracts. Collins Aerospace was one of 37 companies to be selected for this $32.5B ceiling award... The Training Systems Acquisition IV contract will assess emerging tools and technologies to bring increased training capabilities to the Air Force, supporting a variety of aircraft platforms as well as non-aircraft, system-specific simulation and training requirements," the company stated.

13:00 EDT Avista signs renewable natural gas contract - Avista recently signed an agreement with Pine Creek RNG to purchase renewable natural gas to be produced at the Bayview Landfill in Elberta, Utah. The Bayview Landfill project is expected to begin production in early 2024 with an expected output of 1.6 million therms annually.

12:33 EDT Genenta Science SpA(ADR) trading resumes

12:28 EDT Genenta Science SpA(ADR) trading halted, volatility trading pause

12:06 EDT AG Mortgage offers to acquire Western Asset Mortgage for $9.88 per share - AG Mortgage Investment Trust (MITT) announced this morning that it submitted a proposal to the board of Western Asset Mortgage Capital (WMC) to acquire WMC for a fixed exchange ratio, representing an implied price of $9.88 per share, consisting of a stock consideration of $8.90 per share and cash consideration of 98c per share. The offer represents an 18.2% premium to WMC's closing share price, the company said in a statement. "We believe combining WMC with MITT would result in a focused, residential mortgage REIT with an optimized capital structure and significant growth potential and value-creating opportunities for the combined company's stockholders. Our complementary core competences in residential mortgage credit would establish an even more efficient and competitive company. Importantly, our proposal provides closing certainty and does not accelerate WMC's convertible notes, while also benefiting WMC stockholders, particularly given the cash consideration we describe in greater detail below, significant opportunities for cost synergies, and expected earnings accretion following the transaction's close. We stand ready to engage meaningfully with the WMC Board of Directors and request that the WMC Board properly and expeditiously evaluate our offer given its substantial benefits to all stockholders,"" said AG Mortgage in a letter to the board.

12:00 EDT MediaAlpha falls -10.0% - MediaAlpha is down -10.0%, or -$1.09 to $9.84.

12:00 EDT Progressive falls -12.2% - Progressive is down -12.2%, or -$16.08 to $116.03.

12:00 EDT Skillz rises 11.1% - Skillz is up 11.1%, or $1.31 to $13.12.

11:58 EDT Genesis Growth Tech Acquisition Corp trading resumes

11:31 EDT Duke Energy raises quarterly cash dividend 2c to $1.025 per share - Duke Energy declared a quarterly cash dividend on its common stock of $1.025 per share, an increase of 2c. This dividend is payable on Sept.18 to shareholders of record at the close of business on Aug.18.

11:09 EDT Freyr Battery awarded EUR 100M grant from European Union - Freyr Battery announced that the company has been awarded a EUR 100M grant from the European Union to support development of Freyr's Giga Arctic project in Norway. The grant will be funded through the EU's Innovation Fund, or "EUIF," as part of the EU's efforts to promote localized production of battery solutions. Giga Arctic, which has been under development since Freyr's board of directors sanctioned the start of construction in June 2022, is designed to be a 29 GWh nameplate capacity facility based on the 24M Technologies SemiSolid manufacturing platform and powered with 100% renewable hydroelectricity. "We are delighted with the news we have received from the EU's Innovation Fund to support FREYR's Giga Arctic project. This grant is a recognition that batteries represent the key catalyst of the energy transition supporting regional energy security through faster deployment of renewable energy. Moreover, this significant financial commitment provides timely support to continued development of the Giga Arctic project, which is intended to bring clean battery products to our customers and partners across Europe. We look forward to working with the EUIF as well as the Norwegian Government to unlock further momentum for next generation battery production capacity at GWh scale in Norway," remarked Tom Einar Jensen, Freyr's Co-Founder and CEO.

10:55 EDT Delta sees capacity growth normalizing to mid-single digits in 2024

10:42 EDT FREYR Battery trading halted, news pending

10:24 EDT Delta Air Lines: Paying down debt is a priority

10:23 EDT EdtechX Holdings Acquisition Corp II trading halted, volatility trading pause

10:12 EDT Delta: Air travel is number 1 big-ticket purchase priority for consumers

10:10 EDT Delta Air Lines: Aviation infrastructure still fragile

10:09 EDT Delta Air Lines sees capacity constraints remaining for 'extended period'

10:07 EDT Community college places order for 15 Knightscope K1 Blue Light Towers - Knightscope announces a new order for 15 of its K1 Blue Light Emergency Towers from a California public community college.

10:00 EDT Progressive falls -7.9% - Progressive is down -7.9%, or -$10.48 to $121.63.

10:00 EDT Vertical Capital Income Fund falls -9.4% - Vertical Capital Income Fund is down -9.4%, or -79c to $7.65.

10:00 EDT Doma Holdings rises 11.1% - Doma Holdings is up 11.1%, or 80c to $8.00.

09:54 EDT FTC says Celsius and affiliates agree to $4.7B judgment - The Federal Trade Commission announced a settlement with bankrupt cryptocurrency platform Celsius Network that will permanently ban it from handling consumers' assets and charged three former executives with tricking consumers into transferring cryptocurrency onto the platform by falsely promising that deposits would be safe and always available. The proposed settlement with Celsius and its affiliates will permanently ban the companies from offering, marketing, or promoting any product or service that could be used to deposit, exchange, invest, or withdraw any assets. The companies also agreed to a judgment of $4.7B, which will be suspended to permit Celsius to return its remaining assets to consumers in bankruptcy proceedings, the FTC stated. The former executives - ex-CEO and co-founder Alexander Mashinsky along with Celsius's other co-founders Shlomi Daniel Leon and Hanoch "Nuke" Goldstein - have not agreed to a settlement and the FTC's case against them will proceed in federal court. Reference Link

09:47 EDT Vertical Capital Income Fund falls -8.2% - Vertical Capital Income Fund is down -8.2%, or -69c to $7.75.

09:47 EDT Imax rises 6.1% - Imax is up 6.1%, or $1.05 to $18.13.

09:47 EDT Gaotu Techedu rises 7.1% - Gaotu Techedu is up 7.1%, or 24c to $3.63.

09:33 EDT Co-Diagnostics awarded $1.2M in funding from NIH for Co-Dx PCR Home platform - Co-Diagnostics has been awarded $1.2M in funding from the National Institutes of Health as part of the Rapid Acceleration of Diagnostics Tech program for completion of its upcoming upper respiratory panel on the Company's Co-Dx PCR Home testing platform. Co-Diagnostics will utilize the funds from the RADx Tech award to complete development of its flu A/B, COVID-19, and RSV multiplex test, preparatory for that test to begin clinical trials on the Co-Dx PCR Home. The Co-Dx PCR Home is currently undergoing clinical evaluations in anticipation of its submission to the FDA and an initial product launch for a COVID-19 test.

09:26 EDT Udemy appoints Sohaib Abbasi as independent chair of board - Udemy has appointed Sohaib Abbasi as Independent Chair of its Board of Directors, effective immediately. Abbasi succeeds Jeff Lieberman, who has served as Interim Chair since March 2023. Lieberman will remain on the board as a director. The appointment of an Independent Chair further emphasizes Udemy's ongoing commitment to strong governance and shareholder interests. Abbasi served as the chairman and chief executive officer of Informatica from 2004 to 2015

09:22 EDT Maris-Tech receives $392,000 order from electro-optical solutions provider - Maris-Tech had received a new order from a leading Indian electro-optics and surveillance systems provider. The order is for a product based on Maris-Tech's innovative Mars technology, featuring advanced video streaming and recording capabilities, and it is expected to be delivered to the customer during the year 2023.

09:17 EDT Kartoon Studios announces Kartoon Films - Kartoon Studios announced a package of original full-length animated features for children based on existing Kartoon Studios properties, which will leverage AI technology to animate more content, in less time and reduce expenses, while staying true to the Company's core focus on human creativity and positive content. The new films will debut exclusively across the Kartoon Channel! U.S. streaming platforms in 2024, as well as being distributed to broadcasters and streamers globally.

09:15 EDT ARIA Cybersecurity launches solution for protecting OT environments - ARIA Cybersecurity Solutions launched a solution for protecting operational technology environments, which stops even the most advanced and dangerous cyberattacks before they do harm. ARIA Zero Trust PROTECT is an advanced AI-driven endpoint protection solution that protects devices running critical applications in sectors such as pharmaceuticals, transportation, energy, utilities, smart manufacturing, and autonomous vehicles.

09:12 EDT Lucy Scientific Discovery announces appointment of Nanula as CEO - Lucy Scientific Discovery (LSDI) announced the appointment of current Executive Chairman Richard Nanula as the new Chief Executive Officer, effective immediately. Nanula will retain his Chairman role while succeeding Chris McElvany as Chief Executive Officer, who will transition into a consulting role with the Company. Nanula brings to Lucy decades of senior leadership experience from several of the largest companies in the world having been a Senior Executive at The Walt Disney Company (DIS), Colony Capital and Starwood Hotels and Resorts.

09:11 EDT Wrap Technologies announces BolaWrap utilization in Hillsborough County - Wrap Technologies applauds the Hillsborough County Sheriff's Office in Florida for its achievements in deploying the company's BolaWrap solution. Since the launch of its BolaWrap program in July 2021, the Hillsborough County Sheriff's Office has expanded its deployment on three separate occasions, driven by the results and positive outcomes experienced by officers, particularly in encounters involving individuals experiencing a mental health crisis.

09:09 EDT AppHarvest names Tony Martin CEO, Kevin Willis as board chair - AppHarvest named controlled environment agriculture veteran Tony Martin its chief executive officer effective immediately to accelerate its strategic plan, Project New Leaf, which has shown strong progress toward operational efficiencies resulting in higher sales, cost savings and product quality as the company works to increase production across its four-farm network. Martin has served as an AppHarvest board member since October 2022 and as chief operating officer since January of this year. Kevin Willis, who has served on the AppHarvest board since February of 2022, will assume the position of board chair.

09:07 EDT Pretzelmaker opens second drive-thru location in Cedar Rapids, Iowa - Pretzelmaker has officially opened its second drive-thru location in Cedar Rapids, IA. The opening follows the brand's debut of the first drive-thru store model earlier this year in Mason City, IA. The new Pretzelmaker Cedar Rapids drive-thru is located at 1115 Blairs Ferry Road NE, Cedar Rapids, IA 52402 and is open Monday through Saturday 11 a.m. to 8 p.m., and Sunday from 12 p.m. to 6 p.m.

09:06 EDT Flywire partners with Tencent Financial to streamline global tuition payments - Flywire (FLYW) announced that it has partnered with Tencent Financial Technology, Tencent's (TCEHY) fintech arm, to extend Weixin Pay as a payment option for Chinese students and families making education payments abroad. Through this direct partnership with Tencent, Flywire further streamlines the payment experience for students looking to make international tuition and other education-related payments from China. The partnership between Flywire and Tencent Financial Technology applies the same experience Chinese consumers are used to in their daily transactions to cross-border education payments. Through Flywire, Chinese students can pay their education institution using Weixin Pay in their own currency.

09:05 EDT Vale partners with Wabtec to advance rail operations decarbonization - Vale (VALE) announced a partnership with Wabtec Corporation (WAB) to advance the decarbonization of the company's rail operations. The deal includes an order for three of Wabtec's FLXdrive battery locomotives and a collaboration to test ammonia as a potential clean, alternative fuel to replace diesel. The three 100% battery powered FLXdrive locomotives will be used on the Carajas Railroad, or EFC, which runs the world's largest iron ore train consisting of 330 railcars transporting 45,000 tons. Today, three to four diesel locomotives pull the train. Once delivered, the FLXdrives will join the diesel locomotives to form Brazil's first hybrid consist pulling the train uphill for 140 kilometers in Acailandia, in the state of Maranhao, where fuel consumption is the highest. The FLXdrives will replace the two diesel locomotives, known as "dynamic helpers", that are used to pull the train uphill today. Wabtec will build the FLXdrive locomotives at its plant in Contagem. The locomotives' delivery is forecast for 2026.

09:04 EDT Synaptogenix's Bryostatin-1 in Alzheimer's shows positive Phase 2 results - Synaptogenix announced that an abstract featuring secondary endpoint data of its National Institutes of Health sponsored Phase 2 Bryostatin-1 trial was accepted for presentation at the 11th International Brain Research Organization World Congress of Neuroscience to be held in September 2023 in Spain. In the recently completed Phase 2 clinical trial of Bryostatin-1, two cohorts were studied: a Moderate Cohort and a Severe Cohort. While Moderate Cohort patients showed no significant benefit, for patients of the Severe Cohort, representing the patient population with the most advanced Alzheimer's disease - AD -, nearly all pre-specified secondary endpoints were achieved with statistical significance. Data also showed statistical significance in exploratory secondary endpoints for this Severe Cohort, and post hoc analysis was positive.

09:03 EDT CNH Industrial highlights solar panel installations at sites - The company said, "CNH Industrial is committed to building a sustainable future through the design and development of our products and the plants where we build them. We have set an emissions target to have a 90% share of renewable electricity at these sites by 2030. 'We are proud to be using recycled energy,' declares Amit Kumar Tiwari, Electrical Lead at the CASE Construction Equipment manufacturing plant in Pithampur, India. His enthusiasm about the ecofriendly developments at our operations in India can be seen in a new film at bit.ly/BreakingNewGround_en. Through interviews with employees and our Head of Energy, we showcase how the solar panel installations at our sites are helping to attain our renewable energy goals. And the data is impressive: a reduction of around 26,000 tons of CO2 emissions over 10 years at our Greater Noida, India plant, while the Pithampur, India manufacturing facility gets 20% of its energy from solar power."

09:02 EDT ClearSign partner Narion awarded $250,000 phase one SBIR grant - ClearSign Technologies announced that the company's collaboration partner, Narion has been awarded a $250,000 phase one SBIR grant from the Department of Energy to develop a technology utilizing ClearSign's sensor, which will allow Narion to enable the efficient and complete combustion of flared waste gas.

08:58 EDT Azure Power changes independent registered public accounting firm - Azure Power announced a change in its independent registered public accounting firm. The board approved the appointment of ASA & Associates as an independent public accounting firm registered with the Public Company Accounting Oversight Board for the company's US GAAP consolidated financial statements for FY22, pursuant to the resignation of S.R. Batliboi. ASA is a full-service firm of accountants, tax advisory, corporate strategy and compliance experts with over 32 years of experience and over 1,000 associates. S.R. Batliboi, member firm of Ernst and Young Global, tendered its resignations as the independent registered public accounting firm of the company and the Auditors of the subsidiary companies of APIPL. In its letter, SRB stated that in view of the fact that they are yet to receive the information that they have requested to complete their audit work inclusive of the March 31, 2022 draft financial statements, US annual filing, associated books and records, and our conclusions and representations on the impact of the whistle blower complaints, it is not possible for them to complete the audit of the financial statements within the timeline expected by the company. They have therefore tendered their resignation.

08:47 EDT Quest Diagnostics launches novel prostate cancer test - Quest Diagnostics launched a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with Envision Sciences, an Australian-based clinical diagnostics company developing a pipeline of biomarker-based cancer diagnostic and prognostic tests in tissue and blood. The new, tissue-based test service is intended to address the pressing clinical need for tests to help identify and differentiate potentially aggressive cases of prostate cancer in men. Quest developed and validated the laboratory test under an intellectual property license agreement with Envision for use of Envision's proprietary biomarker and immunohistochemistry technology, which includes Envision's staining technology and novel biomarkers.

08:45 EDT American Resources' ReElement selects Marion, Indiana for refining facility - American Resources Corporation's wholly owned subsidiary, ReElement Technologies has taken a controlling interest in the former RCA Thomson plant in Marion, Indiana, comprising 425,000 square feet manufacturing capacity on a 42 acre total campus for ReElement Technologies' rare earth and battery material refining. Marion, Indiana was selected by ReElement Technologies for this next phase of expansion after several months of careful analysis and examination of several potential sites throughout the Midwest. The resulting size and scope of the facility is dependent upon finalizing and receiving city and state incentives, which is anticipated to support a range of 30 jobs with no incentives and scaling up to approximately 300 jobs with full anticipated incentives. At full scope, the site and facility will provide for: 42 acres with ample areas for operations and future development; 425,000 square feet of existing production facility space and support structures; 250,000 square feet of additional foundation-ready space to expand production facilities or structures for further growth; Production of Rare Earth Elements: Target initial capacity of 2 metric tons per day of purified rare earth elements sourced from end-of-life magnets, such as those found in high-efficiency motors, electric vehicles, wind turbines, power tools, and hard drives. This will be the largest such producer of heavy rare earth elements outside of China. Production of Battery Materials: Target initial capacity 50 metric tons per day of lithium-ion battery input material sourced from end-of-life batteries and manufacturing waste, such as those found from electric vehicle batteries, power tool batteries, specialty batteries, with the ability to process a wide range of lithium-ion battery chemistries including Lithium Iron Phosphate and Nickle Manganese Cobalt. Providing for a complete, domestic beginning-to-end solution of the battery and magnet supply chain: The campus is being designed to drive collaboration with industry partners in the battery and magnet supply chain by creating co-locating partners in the electrified value chain within the campus; reducing costs, maximizing productivity, and significantly reducing the carbon footprint of products produced. Rail loadout on site along with 37 truck bays for enhanced transportation logistics, including access to major highways and interstate travel, with a central location to many potential customers within the automobile, battery and magnet industries in the US battery belt. Exceptional community support for ReElement Technologies, along with access to several important educational institutions, such as Indiana Wesleyan University, Ivy Tech Community College, Taylor University and Purdue University which can provide skilled personnel to ReElement Technologies' expanding workforce.

08:44 EDT TriumphPay audit to streamline invoicing for RXO - TriumphPay (TFIN) announced that RXO (RXO) is actively using the TriumphPay audit processing platform. The TriumphPay open payments network has rapidly expanded since its launch in January 2022, creating a more secure hub for the presentment, audit and payment of invoices in the transportation industry. "At RXO, we are focused on providing exceptional service to shippers and carriers by leveraging our cutting-edge technology and massive capacity. Partnering with TriumphPay will help us continue to streamline our invoicing process so carriers are paid more quickly," said Jamie Harris, chief financial officer of RXO.

08:43 EDT EHang, Shenzhen's Bao'an district form strategic partnership - EHang Holdings announced that it has signed a Memorandum of Understanding, MOU, with the Bao'an District Government of Shenzhen municipality on a comprehensive strategic partnership in urban air mobility for commercial operations of EH216-S AAVs following the completion of the EH216-S type certification. Bao'an District and EHang will jointly develop UAM use cases, systems and routes to build Shenzhen as a national low-altitude economy development demonstration city. Leveraging the high-quality resources of Bao'an District, EHang plans to establish the Company's first UAM Operation Demonstration Center at the OH Bay, an urban landmark in Shenzhen, and to launch aerial tourism and sightseeing experience services with EH216-S AAVs. Under this strategic partnership, the Bao'an District Government will provide comprehensive support for EH216-S AAV procurement, financial leasing, infrastructure construction, and low-altitude operations in the area. Based on that, EHang plans to establish an EH216-S AAV Assembly and Delivery Center, a Research and Development Testing Center, as well as a Maintenance Support Center in Bao'an District in the future to ensure local UAM operational services.

08:41 EDT Inogen buys France-based Physio-Assist for up to $45M in accretive deal - Inogen announced that the company has entered into a definitive agreement to purchase Physio-Assist SAS, a privately-held company headquartered in France. Physio-Assist developed and manufactures Simeox, a technology-enabled airway clearance device to treat a condition in the lungs known as bronchiectasis, where the lung's bronchi become damaged and widened, that is often present in cystic fibrosis and chronic obstructive pulmonary disease. "Simeox imminently expands our product offering in EMEA, and potentially in the US to serve COPD and other chronic disease patients who suffer from bronchiectasis with an innovative, non-invasive, and next generation airway clearance solution. We believe this is a compelling transaction, as it expands our addressable market opportunity, enhances our long-term growth and profitability, and is expected to generate an attractive return on investment."...Inogen will pay approximately $32M in cash net of debt payable at closing, plus potential future cash performance-based milestone payments based on achievement of goals related to FDA clearance of the device. The total consideration, if all milestones are achieved, will not exceed $45M. The amount of the performance-based milestones may also be adjusted net of related development costs. In 2023, the acquisition is expected to be immaterial to Inogen's revenue and immediately accretive to gross margin. Given the clinical and commercial investment required to obtain FDA clearance and launch Simeox in the US, the transaction is expected to be accretive to adjusted earnings beginning in 2027. The transaction, which has been approved by the Board of Directors of Inogen and Physio-Assist, is subject to the satisfaction of customary closing conditions, including Foreign Investment Authority approval from the French Ministry of Economy. The transaction is expected to close in the fourth quarter of 2023. I

08:41 EDT Disney CEO says notion company 'sexualizing children' is 'preposterous' - Disney CEO Bob Iger says the notion that the company is "sexualizing children" is "preposterous" and "inaccurate." Iger made the comments while being interviewed on CNBC.

08:40 EDT Capricor Therapeutics announces appointment of Auwaerter to board of directors - Capricor Therapeutics announced the appointment of Paul Auwaerter, M.D. to its Board of Directors, effective immediately. Dr. Auwaerter brings over three decades of experience in internal medicine and infectious disease to Capricor.

08:39 EDT Perrigo announces FDA approval of Opill - Perrigo announced that the U.S. FDA approved Opill, a progestin-only daily oral contraceptive, for over-the-counter use for all ages. Opill is the first ever birth control pill available over the counter in the United States. Opill, which consists of 0.075 mg norgestrel, will be available in store and online at leading retailers across the U.S. early in the first quarter of 2024.

08:38 EDT Iger says 'last thing I want for the company is to be drawn into culture wars'

08:37 EDT 3D Systems announces enhanced, binding offer to combine with Stratasys - 3D Systems (DDD) announced an enhanced, binding offer to combine with Stratasys (SSYS). Each Stratasys share will convert into $7.50 in cash and 1.5444 shares of the combined company, representing ownership by the Stratasys shareholders, in the aggregate, of approximately 44% of the shares of the combined company, in addition to the approximately $540 million of aggregate cash consideration being offered. The binding offer by 3D Systems represents compelling value for Stratasys shareholders by any measure: Implied value per Stratasys share of $24.07, based on 3D Systems July 12, 2023 closing share price, representing a 62% premium to the closing price per Stratasys share on May 24, 2023, the last trading day prior to the announcement of the proposed transaction by Stratasys with Desktop Metal. Implied value of approximately $28 per Stratasys share, or an approximately 80% premium, inclusive of $100 million of mutually identified and agreed upon cost synergies. Represents a ~15% improvement to 3D Systems' proposal submitted to the Stratasys Board on May 30, 2023. Concurrently with the announcement of this binding offer, 3D Systems has delivered to Stratasys a signed merger agreement in escrow. This merger agreement, which lays out the details of the merger and, as required, will be filed on Form 8-K with the SEC by 3D Systems, now awaits countersignature by Stratasys. The terms outlined in 3D Systems' merger agreement, including the representations, warranties, covenants, closing conditions and termination rights, were designed to track those in the Desktop Metal merger agreement in order to offer Stratasys and its shareholders at least as much certainty as the Desktop Metal transaction. These terms include: 3D Systems Picks Up the Desktop Metal Termination Fees: 3D Systems will pay, on behalf of Stratasys, the full amount of any termination fees owing to Desktop Metal, as a result of the failure to obtain Stratasys' shareholder approval of such agreement and as a result of the entrance by Stratasys into the merger agreement with 3D Systems. No Financing Condition: 3D Systems will fund the cash consideration from the pro forma balance sheet of the combined company and, as such, the proposed merger is not subject to any debt or equity financing condition. Right to Elect Form of Consideration: Each Stratasys shareholder will have the right to elect to receive its preferred mix of cash and stock consideration, subject to the shareholder-friendly election, cap and proration mechanisms. Advantageous tax and capital markets structure: Stratasys shareholders will receive shares of a Delaware-incorporated, domestic SEC registrant. This transition away from holding shares of a foreign private issuer will result in their holding shares in an issuer with access to a significantly broader capital markets base. Moreover, while Stratasys shareholders will need to consult with their own tax advisors, this structure will generally enable Stratasys shareholders to receive the share consideration on a tax-free basis. Regulatory Clearance Certainty with No CFIUS Risks: 3D Systems is confident that all applicable regulatory clearances will be obtained and therefore makes a strong commitment to obtain requisite regulatory clearances. In addition, in contrast to the proposed Desktop Metal merger, no CFIUS approval is required for the proposed combination of Stratasys and 3D Systems. Removal of Unusual Desktop Metal Terms: The Desktop Metal merger agreement contains unusual terms, including a requirement for a number of existing contracts of Desktop Metal to be modified or terminated in advance of closing, a provision for the payment of a termination fee of $19 million by Stratasys to Desktop Metal if these contracts are not modified or terminated, and a provision that the Desktop Metal merger agreement may be terminated if a shareholder were to hold more than 50% of either company. The merger agreement with 3D Systems has no such contingencies hanging over the pathway of the shareholders of both companies to realize superior value upon consummation. Right of Stratasys to Terminate to Accept a Superior Proposal: In contrast to the Desktop Metal merger agreement, Stratasys will have the right to terminate this merger agreement to enter into a superior proposal, ensuring that the shareholders of Stratasys are able to receive, at the end of the day, the best value attainable for their shares.

08:36 EDT Coherus, Superior announces national distribution agreement for YUSIMRY - Coherus BioSciences and specialty pharmacy Superior Biologics announced a national distribution agreement for YUSIMRY at a price of $995 per carton of two autoinjectors, a discount of more than 85% compared to Humira, currently priced at $6,922 per carton of two pens. "Coherus is pleased to work with Superior Biologics for nationwide distribution of YUSIMRY, providing patients and their plan sponsors access to a high-quality, safe, and effective treatment at significant savings compared to Humira," said Denny Lanfear, Coherus' Chairman and Chief Executive Officer. "Superior Biologics is an ideal partner for the distribution of YUSIMRY based on their commitment to quality patient service and care, their extensive experience working with manufacturers, patients, physicians, and plan sponsors, and their nationwide reach. Through this unique distribution partnership, we can bring YUSIMRY immediately to patients throughout the United States." Coherus first announced the release of YUSIMRY on July 3, 2023 at an annual price of less than $13,000 compared to nearly $90,000 for Humira based on the company's investment in robust large-scale manufacturing, passing the savings on directly to patients in need. The agreement is the first between the two companies, marking an innovative distribution model that will serve patients effectively and allow employers to achieve significant savings in their specialty drug costs.

08:35 EDT Color Star Technology and Three Angles Production parnter in Southeast Asia - Color Star Technology subsidiary Color Metaverse and Three Angles Production have entered into a framework strategic cooperation agreement with plans to increase development efforts within the live events industry around the world and specifically in Southeast Asia, planned to become one of the key areas for Color Star's business development. Three Angles is an international media and entertainment company with offices in Australia, Indonesia, the Philippines, Singapore, and Korea. The company has been involved in the production of shows for Britney Spears, Chungha, THE BOYZ, amongst others. Three Angles has a range of performance resources specifically in Singapore and Malaysia. The partnership which is planned to be set forth in a definitive agreement aims to improve Color Star's live performance business in Southeast Asia.

08:34 EDT T. Rowe Price reports preliminary AUM $1.4T at June 30 - Preliminary net outflows were $6.7B for June and $20B for the quarter-ended June 2023.

08:33 EDT Orgenesis appoints Elliot Maltz as CFO - Orgenesis announced the appointment of Elliot Maltz as Chief Financial Officer, effective September 1, 2023. Mr. Maltz succeeds Mr. Neil Reithinger, who is resigning following years of dedicated service and will remain with the Company until he completes his transition of duties, through September 1, 2023. Mr. Maltz, previously served as the CFO of Gelesis.

08:33 EDT Bridgeline Digital's AI-powered search software chosen by Voltus GmbH - Bridgeline Digital announced that Voltus GmbH, a pioneering electrical online distributor, has chosen Bridgeline's AI-powered search software to drive its ecommerce business. Voltus selected Bridgeline because of its Artificial Intelligence and NLP Search capabilities for its expansive catalog across multiple languages including German and English. With 80,000 products, Voltus needed a partner with proven success for large B2B catalogs and Bridgeline's expertise in the electrical distributor industry made it a natural fit. "Bridgeline has launched a strategic focus on the electrical distributor industry with specialized features and service expertise that allows companies like Voltus to increase revenue with industry-intelligence built directly into our search product," said Ari Kahn, CEO of Bridgeline Digital. "Our professional services team deeply understands the electrical distributor space and offers knowledge engineering and other solutions."

08:32 EDT SurgePays provides company updates for shareholders - SurgePays provided a Company update. A recent report, which contains numerous errors of fact and misleading and libelous content, appears to be a deliberate attempt to undermine the positive work SurgePays is undertaking in low-income communities to provide wireless and financial services to the underbanked and underserved. Chairman and CEO Brian Cox stated, "SurgePays, as a company, would like to set the record straight and confirm that its controls, policies, and procedures to enroll eligible households in the Affordable Connectivity Program are vetted and compliant. We also voluntarily contract a third-party compliance company to oversee regulatory filings, reporting calculations, and manage audits. Hundreds of thousands of households in need benefit from our team's hard work every day, and we take this responsibility very seriously. As a matter of fact, our entire business model is corporately responsible." Cox concluded: "While it's annoying for shareholders to deal with these types of efforts, the effects should not last long when we are expecting to report a net income of over $6 million in the second quarter alone, and we are still in the early phases of our growth pattern. We will remain laser-focused on executing an exciting growth strategy while providing essential products and services that underserved folks need and want."

08:27 EDT GSK begins shipping flu vaccines to US healthcare providers ahead of flu season - GSK announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2023-24 flu season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration FDA . GSK expects to distribute over 40M doses of its influenza vaccine to the US market. Both FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT will be available in a 0.5mL, single-dose, pre-filled syringe, and are indicated for patients six months and older. CDC recommends an annual flu vaccination for anyone aged six months and older who does not have contraindications.

08:26 EDT Iger says 'right decision' to go into streaming, 'will be a growth business' - Iger says "not going to rule out" doing "some licensing" of content. Disney CEO Bob Iger continues being interviewed from the Sun Valley conference by CNBC's David Faber.

08:22 EDT Corning announces launch of Corning Viridian Vials - Corning launched Corning Viridian Vials, the latest innovation in its expanding pharmaceutical glass-packaging portfolio. The new technology can improve filling-line efficiency by up to 50% while reducing vial-manufacturing carbon-dioxide-equivalent emissions by up to 30%. "Corning continues to push the boundaries of glass technology to help our customers tackle their most complex challenges," said Ron Verkleeren, senior vice president and general manager, Corning Life Sciences. "Viridian Vials' cutting-edge coating technology allows our customers to deliver medications safely and efficiently - for both patients and the planet." Viridian Vials use 20% less glass material than conventional glass vials, with no impact on the quality or safety of the vial. This reduction in glass material lowers manufacturing and transportation-related emissions by up to 30% and decreases the total amount of glass entering the waste stream.

08:18 EDT Disney CEO Iger sees coming to agreement with Comcast to buy rest of Hulu - The Disney+ and Hulu apps will be merged by the end of this year, Iger says. Iger says Disney is "better off having Hulu than not having Hulu." Disney (DIS) CEO Bob Iger continues being interviewed from the Sun Valley conference by CNBC's David Faber.

08:18 EDT FICO awarded patents related to digital decisioning and fraud that utilize AI - Global analytics software firm FICO has been granted 9 patents, 3 foreign and 6 U.S., related to digital decisioning in the areas of fraud, artificial intelligence AI , and machine learning technology. FICO's extensive industry expertise in building AI and machine learning models provides value to enterprises that adopt FICO Platform and other FICO solutions. FICO's new patents including:"Soft Segmentation Based Rules Optimization for Zero Detection Loss False Positive Reduction" - which covers rules-based financial crime detection for detecting money laundering and fraud while reducing false positive detections. "Mobile Attribute Time-Series Profiling Analytics" - which claims a means to assess the likelihood that a transaction is abnormal based on a behavioral pattern of a mobile device. "Latent Feature Dimensionality Bounds for Robust Machine Learning on High Dimensional Datasets" - which describes a method to identify the number of optimal hidden nodes in a neural network model, leading to the development of more robust and stable machine learning models at the core of responsible AI. This patent is used in FICO Platform. The company named additional patents in its statement. "

08:16 EDT Microchip introduces automotive-qualified 10BASE-T1S ethernet devices - Automotive designers are looking to replace legacy gateway subsystems with technology that can migrate applications to an Ethernet network to easily access information from the edge to the cloud. To provide OEMs with automotive-qualified Ethernet solutions, Microchip Technology announces its first automotive-qualified Ethernet PHYs. This family of 10BASE-T1S devices with AEC-Q100 Grade 1 qualification includes the LAN8670, LAN8671 and LAN8672. The LAN8670/1/2 10BASE-T1S Ethernet PHYs are functional safety ready and designed for use in ISO 26262 applications. These devices now make it possible to connect low-speed devices that previously required their own communication systems into a standard Ethernet system in automotive applications.

08:15 EDT Medavail announces enhanced API integration with Texas Health Resources - MedAvail announced it has successfully achieved integration between MedAvail's Remote Dispensing System and its largest partner, Texas Health Resources. "The value proposition of the MedCenter extends to both clinics and patients alike, and the streamlined integration with Texas Health Resources via this new interface has been shown to reduce prescription dispense times by up to 36%, leading to higher patient satisfaction, while increasing prescription throughput by greater than 10%, which helps address current and worsening pharmacy staffing challenges," stated Mark Doerr, Chief Executive Officer of MedAvail. "In parallel, we continue to work on additional integration interfaces, assisted by our new development partner, Encora, that will make future MedCenter deployments fast and seamless for our current and prospective hospital and clinic partners."

08:14 EDT Iger 'enthusiastic' to take ESPN direct to consumers - Disney CEO Bob Iger continues being interviewed on CNBC.

08:13 EDT Ardelyx announces acceptance of NDA for tenapanor in China - Ardelyx announced that a New Drug Application, NDA, for tenapanor has been accepted for review by China's Center for Drug Evaluation of the National Medical Products Administration, NMPA, for the control of serum phosphorus in adult patients with chronic kidney disease on hemodialysis. This acceptance triggers a $2 million milestone payment to Ardelyx under the terms of the license agreement between Ardelyx and its collaboration partner in China, Shanghai Fosun Pharmaceutical Industrial Development. A potential approval of the NDA submission in China is expected by the end of 2024. Under the terms of its agreement with Fosun Pharma, Ardelyx received an upfront payment of $12 million and is eligible to receive additional developmental and commercialization milestones of up to $110 million and tiered royalty payments on net sales ranging from the mid-teens to 20 percent. Fosun Pharma has the exclusive rights to market and sell tenapanor in China, Hong Kong and Macau.

08:12 EDT FLUENT opens 32nd medical cannabis dispensary in Crestview, Florida - Cansortium announced the opening of its 32nd medical cannabis dispensary in Florida and 35th retail location nationwide. FLUENT Crestview, located at 2385 S Ferdon Blvd, is the northernmost dispensary in the panhandle and will provide convenient access to the people of Crestview and surrounding communities. The dispensary is open daily from 9:00 a.m. to 8:30 p.m. The new 2,500 square foot FLUENT Crestview store will host its grand opening on July 15th, featuring a local vendor market, food trucks, a live DJ and physicians available on site to educate the public about products as well as Florida's medical cannabis program. Throughout the grand opening weekend, all products will be discounted by 50%.

08:11 EDT Mullen Automotive announces launch of EV pilot program with NYPA - Mullen Automotive announces the launch of an EV pilot program with New York Power Authority, NYPA. On July 6, 2023, NYPA began testing Mullen's EV Cargo Van, the all-electric Campus Delivery Utility Vehicle, at its location in upstate New York. "We are very excited to have this pilot with NYPA as they work towards eliminating carbon emissions in the state of New York," said John Schwegman, chief commercial officer of Mullen Automotive. "It takes a few organizations to start the buzz of sustainability in each state. We see NYPA as one of the first movers in New York. We look forward to enhancing NYPA and other fleets' sustainability goals with our various all-electric commercial vehicles."

08:10 EDT Disney CEO says 'we're going to be expansive' examining networks businesses

08:09 EDT Applied UV announces notable expansion in hospitality, leisure sector - Applied UV shared its notable expansion in the hospitality and leisure sector. This growth, fueled by major investments in its 150,000 square foot domestic production, lessens the hospitality industry's dependence on production from China. The hospitality division is experiencing unprecedented growth, with current orders and orders in process totaling approximately $14 million-$15 million including an order in process of over $4 million with a leading hotel brand. "We are thrilled with the growth we're seeing in our hospitality division," said Munn, CEO of Applied UV. "This is a clear indication that our strategy is working, and we are confident that we will meet our $45 million-$50 million revenue projection for 2023." In addition to the company's significant growth in the hospitality sector, Applied UV announces a total company backlog of over $22 million.

08:08 EDT MGP Ingredients announces closure of distillery in Atchison, Kansas - MGP Ingredients announced the planned closure of its distillery in Atchison, Kansas, with the anticipated closure date estimated to be January 2024. The distillery is responsible for producing grain neutral spirits and industrial alcohol products as well as their related co-products. The decision to close this distillery is consistent with the Company's plan to address profitability headwinds associated with its grain neutral spirits and industrial alcohol products within its Distilling Solutions segment. "After careful deliberation, we have concluded that the closure of our Atchison distillery is a necessary step to further align the product categories we participate in and their supporting operations, consistent with our long-term strategic objectives," said David Colo, President and CEO of MGP Ingredients, Inc. "The additional supply of grain neutral spirits and industrial alcohol that has entered the market during the past few years has had a meaningful and structural impact on the market. Combining these market factors with the increase in local corn basis costs during this same time frame has resulted in these product lines no longer being economically viable for the Company. The decision to close the Atchison distillery unfortunately represents the best path forward. We are grateful for the unwavering support and contributions of our distillery employees, customers, suppliers, and the people of Atchison. We are committed to ensuring a smooth transition as we wind down operations at the distillery between now and the end of the year, and we look forward to continuing to support the Atchison community."

08:07 EDT Disney CEO says 'extremely optimistic,' but challenges bigger than anticipated

08:07 EDT Enphase Energy launches IQ batteries in Spain, Portugal - Enphase Energy announced that it has started shipping IQ Batteries to customers in Spain and Portugal. This adds to the product's expanded availability across the European market, including recent launches in France, the Netherlands, and Switzerland.

08:06 EDT Freedom Acquisition I, Complete Solaria announce board approval for combination - The boards of directors of Complete Solaria and Freedom Acquisition, announced approval of the proposed business combination. In addition, Complete Solaria and Freedom announced a $10M commitment from T.J. Rodgers in connection with the proposed business combination. The proposed business combination would bring Complete Solaria to market, as a full system operator with a compelling end to end customer offering including technology, financing, project fulfilment, and service. This transaction will help the company to continue to scale to meet demand, further supporting the acceleration of the global energy transition.

08:06 EDT Disney CEO says 'quite pleased' with how much accomplished since return to post

08:05 EDT Disney CEO Iger says he, board agree 'a lot more work to do' - Disney CEO Bob Iger is being interviewed by CNBC's David Faber from the Sun Valley conference after the company announced last night that Iger has agreed to continue to serve as Chief Executive Officer through December 31, 2026.

08:05 EDT XPO Logistics completes expansion of Norcross, GA service center - XPO announced the completed expansion of its Norcross, GA service center, substantially expanding capacity in metro Atlanta. This marks another important milestone in the implementation of the company's previously announced plan to grow capacity in its North American network with 900 net new doors nationally by the first quarter of 2024. This strategic expansion adds 46 doors in the thriving Georgia market, enabling XPO to handle more freight and provide even better service to customers. The Norcross service center currently employs more than 120 people. With the completion of the expansion, the company expects to hire additional dockworkers and driver sales representatives. In total, XPO employs nearly 700 people across seven service centers in Georgia.

08:04 EDT Exxon Mobil to acquire Denbury in all-stock transaction valued at $4.9B - Exxon Mobil (XOM) announced it has entered into a definitive agreement to acquire Denbury (DEN). The acquisition is an all-stock transaction valued at $4.9B, or $89.45 per share based on ExxonMobil's closing price on July 12, 2023. Under the terms of the agreement, Denbury shareholders will receive 0.84 shares of ExxonMobil for each Denbury share. The company said the transaction synergies are expected to drive strong growth and returns for ExxonMobil. In addition to Denbury's carbon capture and storage assets, the acquisition includes Gulf Coast and Rocky Mountain oil and natural gas operations. These operations consist of proved reserves totaling over 200 million barrels of oil equivalent, with 47,000 oil-equivalent barrels per day of current production, providing immediate operating cash flow and near-term optionality for CO2 offtake and execution of the CCS business. The boards of directors of both companies have unanimously approved the transaction, which is subject to customary regulatory reviews and approvals. It is also subject to approval by Denbury shareholders. The transaction is expected to close in the fourth quarter of 2023.

08:02 EDT Quantum Computing receives third NASA subcontract award - Quantum Computing announces a subcontract award from Bay Area Environmental Research Institute to build and test for NASA Ames an innovative photonic sensor instrument to provide accurate measurement of atmospheric particulates such as clouds, aerosols, smoke flume, volcanic ashes, etc., in order to identify physical properties including size, shape and chemical composition. This award represents the third distinct task order from NASA and is the second research center within NASA to subcontract with the company. Delivery of the photonic sensor is expected during the first quarter of 2024.

07:57 EDT Nikola partnering with Bayotech for zero-emission hydrogen delivery - Nikola and BayoTech, a hydrogen production transportation and storage solutions company, announced an agreement to advance reliable hydrogen supply for zero-emission commercial fuel cell electric vehicle fleets. The strategic supply agreement includes Nikola Class 8 hydrogen fuel cell electric trucks, BayoTech HyFill bulk hydrogen transport trailers, and hydrogen produced at BayoTech's distributed network of hubs. Nikola expects to take delivery of low-carbon hydrogen produced by BayoTech commencing in Missouri this year and California in 2024. Nikola plans to acquire up to 10 BayoTech HyFill transport trailers. BayoTech will purchase up to 50 Nikola Class 8 fuel cell electric vehicles over the next five years, with the first twelve trucks being delivered in 2023 and 2024.

07:39 EDT Dragonfly Energy to be granted U.S. patent for battery pack assembly design - Dragonfly Energy announced it will be awarded a new U.S. patent based on a notice of allowance from the United States Patent and Trademark Office, USPTO, for U.S. Patent Application No. 29/858,079 covering the overall look and design of the assembly case of the Company's GC3 12V 270Ah LiFePO4 deep cycle battery. The Company believes the design of the GC3 battery pack provides for more flexible solutions and increased energy density compared to traditional lead acid and lithium battery form factors. "Our recently allowed design application helps to ensure that when people see a battery pack with our look and design, they know it represents quality," Dr. Denis Phares, CEO of Dragonfly Energy, said. "Our signature deep cycle batteries are well known in our core markets and position us to expand into new industries. In addition to our advancements in cell manufacturing and other fundamental storage technologies, these design patents maximize the value of our innovations."

07:38 EDT Marimed stages 'Boston 280E THC Party' to protest cannabis tax laws - Channeling the Boston Tea Party's rebellious spirit while dressed in traditional colonial garb, MariMed executives and team members staged the 'Boston 280E THC Party' from a boat in Boston Harbor on July 12. In reenacting 1773's "No taxation without representation" revolt, yesterday's event protested Section 280E of the Internal Revenue Service Code. Section 280E burdens cannabis companies with paying significantly higher taxes than most U.S. businesses, often resulting in higher product prices for consumers. MariMed, a leading Massachusetts-based cannabis company, surprised the crowds at Boston Harbor when they boarded the Liberty Star schooner, heaved cargo chests emblazoned with "WEED" overboard and chanted anti-280E slogans. Section 280E is a prime example of the unique obstacles that legal cannabis businesses must navigate that significantly increase the cost of conducting business. When calculating their taxes, Section 280E prevents the deduction of ordinary business expenses associated with "trafficking" a Schedule 1 or 2 controlled substance. Approximately 90% of U.S. adults support its legalization, yet cannabis remains classified as a federally illegal Schedule 1 controlled substance by the U.S. federal government, on par with heroin. Due to Section 280E, cannabis businesses pay much more in taxes than they would if it were repealed, according to Wolf & Company.

07:37 EDT Venus Concept establishes medical advisory board for AI.ME - Venus Concept announced the establishment of a medical advisory board for AI.ME, its next generation robotic platform. The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration in December 2022, for fractional skin resurfacing. The medical advisory board is composed of six leading practicing physicians: Dr. Glynis Ablon, MD, FAAD; Dr. Macrene Alexiades, MD, PhD; Dr. Eric Bernstein, MD, MSE; Dr. James Chao, MD, FASC; Dr. Mitchel Goldman, MD; Dr. Gilly Munavalli MD, MHS, FACMS.

07:36 EDT Conagra Brands expects cost of goods sold inflation to continue into FY24 - The company expects cost of goods sold inflation to continue into fiscal 2024. Guidance anticipates net inflation to be roughly 3%. For FY24: Adjusted operating margin is expected to be between 16% and 16.5%; Net Leverage Ratio of approximately 3.4x; Capital expenditures of approximately $500M; Interest expense of approximately $450M; Adjusted effective tax rate of approximately 24%; Contribution from the company's joint venture, Ardent Mills, is expected to be approximately $150M; Pension income of approximately $0.

07:35 EDT Ayr Wellness enters option agreement to acquire third Ohio dispensary license - AYR Wellness entered an option agreement that provides AYR with the future ability to acquire 100% of the equity interests of Twice the Wellness, an entity provisionally licensed to operate a medical marijuana dispensary in Ohio. Terms of the agreement were not disclosed. Twice the Wellness intends to open a dispensary in Woodmere, Ohio, a suburb of the Cleveland Metropolitan Area. The Company previously entered into option agreements to acquire Daily Releaf, located in Riverside, Ohio, part of the Dayton Metropolitan Area, and Heaven Wellness, located in Clermont County, part of the Greater Cincinnati area. The Company anticipates all three dispensaries to open by year end.

07:33 EDT Reunion Neuroscience shareholders approve proposed plan of arrangement - Reunion Neuroscience announced the voting results of the special meeting of shareholders of Reunion held yesterday, July 12, 2023. At the Meeting, shareholders voted in favour of a special resolution to approve the proposed plan of arrangement under Section 192 of the Canada Business Corporations Act, whereby affiliates of MPM BioImpact would acquire Reunion in an all-cash transaction valued at approximately $13.1M. Pursuant to the terms and conditions of the Arrangement, all Shareholders will be entitled to receive $1.12 in cash for each common share held immediately prior to the effective time of the Arrangement. The Arrangement Resolution required the approval of not less than two-thirds of the votes cast by shareholders present in person or represented by proxy at the Meeting. Shareholders approved the Arrangement Resolution at the Meeting, with 99% of the votes cast at the Meeting in favour of the Arrangement. The Arrangement remains subject to receipt of a final order of the Ontario Superior Court of Justice with respect to the Arrangement and certain other closing conditions described in Reunion's Management Information Circular dated June 13, 2023. Subject to the receipt of the Final Order, all required regulatory approvals and satisfaction of all closing conditions, the Arrangement is expected to be completed on or around July 21, 2023.

07:28 EDT CureVac expands scope of ongoing patent litigations - CureVac announced that it has strengthened its position in the ongoing patent litigations with Pfizer/BioNTech in Germany and the U.S. by expanding the scope of both cases by asserting new intellectual property rights. Patent litigation in Germany, originally filed by CureVac regarding four of its intellectual property rights in June 2022, was strengthened by the addition of a fifth intellectual property right as announced in May 2023.These five intellectual property rights have now been extended by three more recent intellectual property rights: DE202021004123U1 and DE202021004130U1, providing protection to COVID-19 variant adapted vaccines, including the Omicron and XBB1.5 variants and EP4023755, relating to split poly A tail mRNA vaccines. In May 2023, CureVac filed a counterclaim in the U.S. that alleges infringement of nine U.S. patents, expanding the scope of the case beyond the three patents originally named by Pfizer/BioNTech. These nine patents have now been extended by a tenth patent, which relates to mRNA purification methods, a critical part of the overall mRNA manufacturing process. CureVac filed a patent infringement lawsuit in Germany against BioNTech in early June 2022. A first public hearing on this lawsuit will take place on August 15, 2023, before the Regional Court Dusseldorf. A nullity action covering one of the patents at issue was filed by Pfizer/BioNTech in September 2022. A preliminary opinion issued in April 2023 by the German Federal Patent Court supports the validity of the CureVac patent. In the U.S., Pfizer/BioNTech filed its case in late July 2022, asking for confirmation that Comirnaty does not infringe three CureVac patents. These patents are included in the ten U.S. patents of CureVac's counter claim: 11,135,312; 11,149,278; 11,286,492; 11,345,920; 10,760,070; 11,241,493; 11,471,525; 11,576,966; 11,596,686 and 11,667,910

07:24 EDT PepsiCo sees core annual effective tax rate 20% - Says businesses have displayed a high level of resilience in dynamic operating and macroeconomic environments. Says global beverages and convenient foods businesses delivered 11% and 15% organic revenue growth, respectively. Says core margin performance reflects a strong double-digit increase in advertising and marketing spend. Says plans to add additional states for Hard Mountain Dew distribution. Says continues to expect foreign exchange translation to negatively affect reported net revenue and core earnings per share performance by approximately two percentage points. Comments taken from Q2 prepared remarks.

07:23 EDT Zentek COO Brian Bosse resigns, Francis Dube to succeed - Brian Bosse has resigned as COO of Zentek to focus on his role as CEO of Albany Graphite Corp., which is currently a wholly owned subsidiary of Zentek and holds the Albany Graphite Project in Northern Ontario. Francis Dube assumes the role of COO at Zentek with general overall operating responsibilities, while remaining Chairman of the Board.

07:17 EDT Camtek receives orders for 42 systems from tier-1 manufacturers - Camtek has recently received orders for 42 systems from several tier-1 semiconductor manufacturers. A significant portion of the orders are for the manufacture of chiplet modules and High Bandwidth Memory for heterogeneous integration. The systems are expected to be delivered during the second half of 2023. Chiplet module applications include artificial intelligence, data center processing and gaming. The integration of chiplets with several HBM modules results in processing units with superior performance.

07:11 EDT Texas Capital launches first exchange traded fund - Texas Capital Bank Private Wealth Advisors and the Texas Capital Funds Trust announced the launch of the Texas Capital Texas Equity Index ETF. TXS will seek to track the performance of the Texas Capital Texas Equity Index, an index comprised exclusively of public companies headquartered in the state of Texas. At the time of launch, the Index included a diversified group of 216 publicly traded companies, with individual component weights determined first by sector, as defined by the North American Industry Classification System and based on relative contribution to Texas' reported Gross Domestic Product, and then by market capitalization.

07:07 EDT Ginkgo Bioworks awarded research contract for biointelligence and biosecurity - Ginkgo Bioworks has been awarded a research contract from the Intelligence Advanced Research Projects Activity - IARPA -, the research and development arm of the U.S. Intelligence Community, for the Biointelligence and Biosecurity for the Intelligence Community program. Through this program, Ginkgo aims to develop a biosensor that records time-ordered cellular memory for improved traceability and biosecurity. This tool would allow users to monitor the lab conditions and processes to which the cell was subjected.

07:05 EDT Gilat Satellite awarded orders for cellular backhaul over satellite project - Gilat Satellite was awarded millions of dollars in orders for a cellular backhaul over satellite project lead by a Mexican federal agency. Gilat's cellular backhaul solution is being used to connect hundreds of 4G sites within the "CFE Telecommunications and Internet for All" initiative to provide better access to information and communication technologies for all people throughout Mexico.

07:04 EDT Identiv recently completed initial unit order of IoT Pixel tags for Wiliot - Identiv announced that the Company recently completed its initial multi-million unit order of IoT Pixel tags for ambient IoT SaaS company Wiliot. Identiv has since begun production of a follow-on order from Wiliot that was announced on the Company's most recent Earnings call in May 2023. "We are excited to continue partnering with Wiliot to accelerate the development of the revolutionary ambient IoT ecosystem," said Amir Khoshniyati, VP and GM of IoT at Identiv. "With our uninterrupted production of IoT Pixels, Wiliot's customer deployments are able to continue unimpeded, further optimizing their supply chains with the item-level intelligence collected from these breakthrough tags," added Khoshniyati.

07:03 EDT First Wave BioPharma announces initial results from Phase 2 SPAN trial - First Wave BioPharma announced the Company has received topline results from the Company's Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. Initial data from the study indicate the enhanced adrulipase formulation was safe and well tolerated and demonstrated an improvement over prior formulations of adrulipase. However, the preliminary data also indicate that it is likely the primary efficacy endpoint was not achieved. "Preliminary data from the Phase 2 SPAN clinical trial indicate our enhanced microgranule delivery formulation of adrulipase was safe and well tolerated," said James Sapirstein, President and CEO of First Wave BioPharma. "We are in the process of analyzing the dataset and anticipate having a topline review of the primary and secondary endpoints in the September timeframe." Mr. Sapirstein added: "We would like to thank the patients who volunteered to participate in the study and the investigators and their staff at our three participating clinical trial sites for ensuring that the trial was fully enrolled and completed on time."

07:02 EDT Barrick Gold reports preliminary Q2 sales, production of gold, copper - Barrick Gold reported preliminary Q2 sales of 1.00 million ounces of gold and 101 million pounds of copper, as well as preliminary Q2 production of 1.01 million ounces of gold and 107 million pounds of copper. As previously guided, Barrick's gold and copper production in 2023 is expected to increase through the year with the second half being higher than the first six months of 2023. The Company remains on track to achieve full year gold and copper guidance. Preliminary Q2 gold production was higher than Q1, primarily as a result of higher production at Carlin, driven by a return to normal throughput levels following significant maintenance undertaken in the first four months of the year, as well as higher grades at both Kibali and Veladero. This was offset by lower production at: Cortez due to mine sequencing; Turquoise Ridge due to planned autoclave maintenance; and Pueblo Viejo, where tie-in work and commissioning of the plant expansion project impacted production. Compared to Q1, Q2 gold cost of sales per ounce4 is expected to be 3% to 5% lower, total cash costs per ounce are expected to be 1% to 3% lower, and all-in sustaining costs per ounce5 are expected to be up to 2% lower. Preliminary Q2 copper production was higher than Q1, driven primarily by Lumwana. Compared to Q1, Q2 copper cost of sales per pound4 is expected to be 11% to 13% lower, C1 cash costs per pound5 are expected to be 15% to 17% lower, and all-in sustaining costs per pound are expected to be 7% to 9% lower.

07:01 EDT Denali Capital Acquisition says deadline extended to complete combination - Denali Capital Acquisition announced that an aggregate of $825,000 has been deposited into the company's trust account to further extend the period of time the company has to consummate its initial business combination by an additional three months, from the current deadline of July 11 to October 11. This is the second of the two three-month extensions permitted under the company's governing documents.

06:57 EDT Dollar General introduces DG Cash Back rewards program with Ibotta - Dollar General announced its new DG Cash Back Program, which allows customers to earn cash back in their DG Wallet on eligible purchases through the company's partnership with the Ibotta Performance Network. DG Cash Back builds on Dollar General and Ibotta's partnership announced in January 2023 and extends Dollar General's financial services announced in 2022.

06:52 EDT Fastenal says 'global supply chains have normalized versus the prior year' - "We produced operating cash flow of $302.1 in the second quarter of 2023, an increase of 99.8% from the second quarter of 2022, representing 101.4% of the period's net earnings versus 52.7% in the second quarter of 2022. The improvement in operating cash flow, as a percent of net earnings, reflects working capital being a reduced use of cash in the second quarter of 2023 relative to the second quarter of 2022. Global supply chains have normalized versus the prior year, which has reduced the rate of working capital expansion necessary to support our customers' growth. In the first six months of 2023, our operating cash flow was $690.6, an increase of 81.2% from the first six months of 2022, representing 116.4% of the period's net earnings versus 68.5% in the first six months of 2022. The improvement in operating cash flow in the first six months of 2023, as a percent of net earnings, is driven by the same variables as the second quarter of 2023."

06:47 EDT Virgin Galactic announces flight window for second commercial spaceflight - Virgin Galactic announced the flight window for the 'Galactic 02' mission. This mission will be Virgin Galactic's seventh spaceflight, second commercial spaceflight and third spaceflight this year; flying three private passengers to space. The flight window will open on August 10, continuing the company's regular cadence of spaceflights. Details of the flight manifest, including the crew and pilots, will be released at a later date.

06:42 EDT CMA refers Adobe-Figma merger for Phase 2 inquiry - The CMA is investigating the anticipated acquisition by Adobe of Figma and announced it has referred the anticipated acquisition for an in-depth investigation, on the basis that, on the information currently available to it, it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. The statutory deadline for the Phase 2 inquiry is December 27, 2023, the CMA stated. Reference Link

06:32 EDT Clearway Energy sees Q2 revenue decreasing $25M-$30M from lower wind production - Clearway Energy announced that wind production for its fleet in Q2 was approximately 25% below internal median production estimates, which was inclusive of the Alta Wind Complex's wind production at approximately 20% below internal expectations. This deviation in the company's wind production index represented the lowest quarterly production reading in the company's history and resulted in an estimated decrease to Q2 revenue of $25M-$30M. "Despite the abnormally low wind resource in Q2, we continue to have confidence that our long-term outlook remains intact based on historical trends for resource across our asset portfolio," said CEO Christopher Sotos. "Clearway is reiterating its target to achieve the upper range of its 5%-8% annual dividend growth objective through at least 2026 while maintaining an 80-85% long-term payout ratio. We continue to plan to meet this target without needing to issue external equity while adhering to our balance sheet objectives."

06:10 EDT Hecla Mining reports Q2 silver production down 5% vs. previous quarter - Hecla Mining reported preliminary silver and gold production for Q2 and first half of 2023. Year to Date 2023 vs. YTD 2022, Keno Hill produced 184,264 ounces of silver, June throughput of 330 tons per day, silver production increased 13%, gold production decreased 14%, zinc production increased 3%; lead production increased 9%. "Hecla's growing silver production was driven by Lucky Friday's 21% increase compared to the first half of 2022 and a 6% increase at Greens Creek. In addition, Keno Hill, while still testing the mill, operated in its first month at 75% of the targeted 440 tpd throughput using "low-grade" ore to generate almost 200,000 ounces of silver," said Phillips S. Baker, Jr., Hecla's President, and CEO. "Greens Creek's quarterly production was in line with the plan, and Lucky Friday's silver production was the highest since I started at Hecla more than 20 years ago. Our silver operations remain on track to produce about 17 million ounces this year, with Keno Hill expected to produce more than 2.5 million ounces. With expected silver production of about 20 million ounces in 2025, Hecla is the world's fastest-growing established silver producer and the dominant producer of silver in the U.S. and soon Canada." The Greens Creek mine produced 2.4 million ounces of silver and 16,351 ounces of gold in Q2. The mine is expected to achieve 2,600 tpd by 4Q23. Silver production declined compared to Q1, due primarily to expected lower grades, with a 10% increase in gold production attributable to higher grades. The mine remains on track to achieve its production guidance of 9.0-9.5 million ounces of silver this year.

06:04 EDT Better World Acquisition announces liquidation - Better World Acquisition announced that, due to its inability to complete an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation, as amended, the company intends to liquidate and dissolve, effective as of the close of business on July 17, 2023, and will redeem all of the outstanding shares of common stock that were included in the units issued to public stockholders in its initial public offering, at a per-share redemption price of approximately $10.91. As of the close of business on July 17, 2023, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

05:33 EDT Genentech announces OCARINA II trial meets primary, secondary endpoint - Genentech, a member of the Roche Group, announced that the Phase III OCARINA II trial evaluating Ocrevus as a twice a year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with relapsing forms of MS or primary progressive MS. Ocrevus subcutaneous injection was shown to be non-inferior to Ocrevus given by intravenous infusion, or IV, as measured by pharmacokinetics over 12 weeks. Ocrevus subcutaneous injection was also comparable with Ocrevus IV in controlling magnetic resonance imaging, or MRI, lesion activity in the brain over 12 weeks. The safety profile of Ocrevus subcutaneous injection was consistent with that of Ocrevus IV. The Ocrevus 10-minute injection is designed to be administered without the need for IV infrastructure so it has the potential to expand the usage of Ocrevus in MS centers without IV infrastructure or those with IV capacity limitations. It also retains the twice-yearly dosing regimen of Ocrevus IV that has shown high persistence and adherence since becoming a standard of care MS treatment. This provides an additional delivery option so that the administration of Ocrevus can be matched to the individual needs of patients and healthcare professionals.

05:26 EDT Halozyme announces Roche OCARINA II trial met primary, secondary endpoint - Halozyme (HALO) announced that Roche's (RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus with Enhanze as a twice a year 10-minute subcutaneous injection, met its primary and secondary endpoints in patients with relapsing forms of multiple sclerosis, or MS, or primary progressive MS. Ocrevus subcutaneous injection co-formulated with Enhanze, Halozyme's proprietary recombinant human hyaluronidase enzyme, rHuPH20, was shown to be non-inferior to Ocrevus given by intravenous infusion, or IV, as measured by pharmacokinetics at 12 weeks. Ocrevus subcutaneous injection also was comparable to Ocrevus IV in controlling magnetic resonance imaging, or MRI, lesion activity in the brain over 12 weeks. The safety profile of OCREVUS subcutaneous injection was consistent with that of Ocrevus IV. The subcutaneous formulation of Ocrevus with Enhanze retains the twice-yearly dosing regimen of Ocrevus IV that has shown high persistence and adherence since becoming a standard of care MS treatment, potentially providing an additional delivery option for patients and healthcare professionals. Roche will share detailed results from the OCARINA II trial at an upcoming medical meeting and submit the data for regulatory approval to health authorities globally.

05:14 EDT Leidos selected by Leeds Bradford Airport to deliver security technology - Leidos announced Leeds Bradford Airport, or LBA, in England will be deploying the company's ClearScan carry-on baggage scanners, ProPassage Automated Tray Return Systems and the Mosaic Enterprise Software Platform to modernize the airport's security checkpoints.